COVID-19 and arrhythmia: An overview

J Cardiol. 2021 Dec 1:S0914-5087(21)00341-5. doi: 10.1016/j.jjcc.2021.11.019. Online ahead of print.ABSTRACTArrhythmias in COVID-19 patients are associated with hypoxia, myocardial ischemia, cytokines, inflammation, electrolyte abnormalities, pro-arrhythmic or QT-prolonging medications, and underlying heart conditions such as severe congestive heart failure, inherited arrhythmia syndromes, or congenital heart conditions. In the pediatric population, multisystem inflammatory syndrome can lead to cardiac injury and arrhythmias. In addition, arrhythmias and cardiac arrests are most prevalent in the critically ill intensive care unit COVID-19 patient population. This review presents an overview of the association between COVID-19 and arrhythmias by detailing possible pathophysiological mechanisms, existing knowledge of pro-arrhythmic factors, and results from studies in adult and pediatric COVID-19 populations, and the clinical implications.PMID:35074257 | DOI:10.1016/j.jjcc.2021.11.019

Source: Journal of Cardiology - January 25, 2022 Category: Cardiology Authors: Joseph A Varney Vinh S Dong Tiffany Tsao Mariam S Sabir Amanda T Rivera Suhaib Ghula Kevin Emmanuel Moriles Mohana Laasya Cherukuri Rahim Fazal Chelsea B Azevedo Rana Mk Mohamed Garrett R Jackson Shannon E Fleming Diana E Rochez Kirellos S Abbas Jaffer H Source Type: research